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Abstracts / International Journal of Surgery 36 (2016) S31eS132 S33Results: Fibrosis quantity at 1 month is signiﬁcantly associated with graft
survival (p¼0.01 and 95%CI 0.02 to 0.14). Rejection and severity of rejection
were not found to be associated with ﬁbrosis at 1 month. (Rejection:
p¼0.74 and 95%CI -0.02 to 0.03). (Severity: p¼0.81 and 95%CI -0.05 to 0.04)
Conclusion: Renal transplant ﬁbrosis at 1 month post transplant is a
strong indicator of graft survival at 1 year post transplantation.http://dx.doi.org/10.1016/j.ijsu.2016.08.047SARS research & academic prize
0142: CONNEXIN AS A BIOMARKER FOR VENOUS ULCERATION
M. Kanapathy 1,*, A. Mosahebi 1, D. Becker 2, T. Richards 2. 1University
College London, London, UK; 2 Lee Kong Chian School of Medicine, Singapore,
Singapore.
Aim: Leg ulceration is a feared complication of venous insufﬁciency.
Cellular communication via Connexins(Cx) is crucial in wound healing,
upregulation of which is associated with poor wound healing. This study
aims to determine and compare the epidermal Cx levels across stages of
venous disease and further determine if Cx can be used as a biomarker for
risk of venous ulceration.
Method: Patients were assessed according to CEAP classiﬁcation:
C2(n¼10), C4(n¼8), and C6(n¼8). Paired 4mm punch biopsies of the skin
were taken above the ankle(pathological) and above the knee(control).
Tissues were stained for H&E and Immunohistochemistry for Cx43, Cx30
and Cx26.
Results: H&E revealed increased inﬂammation, loss of dermal architecture
and epithelial hyper-thickening with increasing CEAP
(C2:41.94±9.39mm,C4:106.34±24.3mm,C6:674.44±116.21mm, p<0.05).
Overall Cx expression similarly increased across CEAP grades(p<0.05).
Cx43 had highest expression (C2:2061.13,C4:4061.08,C6:11639.60,
p<0.0001). Cx26 had lesser expression in C2 and C4 but increased signif-
icantly in C6 (C2:120.21,C4:558.79,C6:11561.54, p<0.001), similarly Cx30
(C2:145.16,C4:268.88,C6:8286.29, p<0.0001). Signiﬁcant increased
expression of all Cx was seen early in the disease; C2vs.C6(p<0.005) and
C4vs.C6(p<0.005).
Conclusion: Cx proteins were expressed increasingly with disease pro-
gression which starts early in the disease, suggesting that skin is pre-
conditioned for poor wound healing prior to ulceration. Cx can be used as a
biomarker to identify patients that should be treated early.http://dx.doi.org/10.1016/j.ijsu.2016.08.242
0242: APPLICATION OF GOLD NANORODS IN CANCER THERANOSTICS
M. Singh*, E. Nabavi, Y. Zhou, H. Zhao, D. Ma, A.E.G. Cass, G.B. Hanna,
D.S. Elson. Hamlyn Centre for Robotic Surgery, Institute of Global Health
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Aims: Gold nanoparticles can be utilised as photothermal therapeutic
agents because of their strongly enhanced absorption of near infrared light
(NIR) resulting in hyperthermia. We investigate the ﬂuorescence and
photothermal effect from gold nanorods (GNRs) in the diagnostics and
therapy (theranostics) of in vivo upper gastrointestinal adenocarcinoma.
Methods: GNRs were functionalised with a ﬂuorophore (Cy5.5 dye)
modiﬁed with anti-EGFR antibody. Tumour xenografts were established in
immunodeﬁcient mice by subcutaneous inoculation of human oesopha-
geal adenocarcinoma (FLO-1) cells. Functionalised GNRs were then rand-
omised to be administered either intratumourally (IT) or intravenously (IV)
into mice. Fluorescence imaging was performed to observe tumour site
contrast enhancement, followed by tumour irradiation by an 808 nm (NIR)
continuous wave laser for three minutes.
Results: In vivo, bright ﬂuorescence emissions were observed speciﬁcally
emanating from tumour sites, providing diagnostic information. NIR irra-
diation established clinically signiﬁcant hyperthermia in tumoursresulting in consistently successful tumour ablations which were
conﬁrmed histologically. Inductively coupled plasma mass spectrometry
revealed no evidence of harmful organ accumulation of gold.
Conclusions: Fluorescence imaging of GNRs that localise to cancerous
tissue enhances cancer diagnosis. With a single application of NIR light,
this minimally invasive and clinically translatable technique can effectively
and safely induce irreversible tumour photodestruction.http://dx.doi.org/10.1016/j.ijsu.2016.08.2430521: TRO40303 REDUCES MITOCHONDRIAL INJURY AND AMELIO-
RATES EXPERIMENTAL ACUTE PANCREATITIS
M. Ahsan Javed 1,*, L. Wen 1, M. Awais 1, M. Chvanov 1, T. Bordet 2,
M. Michaud 2, S. Schaller 2, R. Pruss 2, A. Tepikin 1, D. Criddle 1, R. Sutton 1.
1NIHR Liverpool Pancreas Biomedical Research Unit, Liverpool, UK;
2 TROPHOS, Marseille, France.
Introduction: Mitochondrial permeability transition pore (MPTP) inhibi-
tion is a promising therapeutic strategy for treatment of acute pancreatitis
(AP). We investigated the effects of TRO40303on MPTP opening and ne-
crosis in pancreatic acinar cells (PACs) and evaluated its efﬁcacy in
experimental AP (EAP).
Methods: Mitochondrial membrane potential (DjM; TMRM), cytosolic
Ca2+ levels ([Ca2+]C; Fluo-4) and necrosis (PI) were evaluated in freshly
isolated murine and human PACs in the presence and absence of bile acid
(TLCS) or fatty acid ethyl ester (POAEE) using confocal microscopy. EAPwas
induced by intraperitoneal (IP) caerulein injections, retrograde pancreatic
ductal TLCS infusion or IP injections of palmitoleic acid and ethanol.
Liposomal TRO40303 was given post AP induction. AP was assessed by
standard biomarkers and blinded histopathology.
Results: TRO40303 protected loss of DjM induced by 500 mM TLCS or 100
mM POAEE in isolated PAC and improved [Ca2+]C clearance. TRO40303
reduced necrosis in murine and human PACs (p<0.05). TR040303 signiﬁ-
cantly reduced serum amylase, pancreatic trypsin, pancreatic and lung
myeloperoxidase and histopathological scores in all models of EAP.
Conclusion: TRO40303 protects mitochondria, reduces necrosis and
ameliorates the severity of three different models of EAP. TR040303 is a
candidate drug for the treatment of human AP.http://dx.doi.org/10.1016/j.ijsu.2016.08.2441122: FIELD CANCERISATION IN COLORECTAL CANCER: CHARACTERISA-
TION OF THE GENE EXPRESSION PROFILE OF THE MUCOSAL FIELD
AROUND COLORECTAL CANCERS AND POLYPS
A. Patel 1,*, Y. Wang 1, J. Moore 1, G. Tripathi 1, N. Williams 2,
R. Arasaradnam1. 1University of Warwick, Coventry, UK; 2University
Hospitals of Coventry and Warwickshire NHS Trust, Coventry, UK.
Aim: Field cancerisation describes genetic changes in the macroscopically
normal colonic mucosa (MNM) around a cancer which render it prema-
lignant without morphological change. This study aimed to characterise
the gene expression proﬁle in the MNM around cancer and polyps
compared to control subjects.
Methods: Subjects (n¼15) were recruited and mucosal pinch biopsies
taken. A two channel micro-array experiment was performed (SurePrint
G3 Human Gene Expression 8x60K Gene Expression array). Genes (>1.5
fold different, p value of<0.05) were selected and analysed using PANTHER
bioinformatics software.
Results: In total, 1665 genes were differentially expressed. The MNM
around polyps demonstrated differential gene expression of genes
involved in cell adhesion, cell morphology and cellular process. In com-
parison, genes responsible for the immune response, antigen processing
and natural killer cell activation (fold enrichment >5, p<0.001) were found
with transition to cancer. Comparing cancer to polyp identiﬁed genes that
participate in cell signalling, protein degradation and microtubule binding
(fold enrichment 3.01, p<0.001: 2.66, P<0.001 and 3.62, p<0.001,
respectively).
